Epidural Intervention of Spinal Nerves With Tumor Necrosis Factor-Alpha Inhibitor

计划入组 90 人 · 首次发布于 2019 年 8 月 20 日

A Pragmatic Trial of Interleukin-17 Inhibition Versus Janus Kinase Inhibition After Tumor Necrosis Factor-alpha Inhibitor Failure in Axial Spondyloarthritis

计划入组 40 人 · 首次发布于 2026 年 8 月 18 日

A Study on Assessment of STELARA and Tumor Necrosis Factor Alpha Inhibitor Therapies in Participants With Psoriatic Arthritis

计划入组 991 人 · 首次发布于 2015 年 12 月 11 日

alpha-tumor necrosis factor-thymosin-alpha-1

human tumor necrosis factor alpha derivative 3a

Recombinant alpha-tumor necrosis factor-thymosin-alpha-1(Pharmaclon)

MAGNESIUM FACTOR PTY LTD

Australia

Alpha Metallurgical

United States

Stiftung Swiss Tumor Institute

Switzerland

Ignite Biomedical's AI-Driven TNFi Treatment Response Predictor Achieves Analytical Validation

Biologic Drug Costs for Psoriasis More Than Doubled Between 2007-2021, Study Reveals

Cadrenal Therapeutics Acquires eXIthera's Factor XIa Inhibitor Portfolio in $15M Deal